Finance

Beta
Lists
2696:HKG
Shanghai Henlius Biotech Inc
HK$55.30
-8.14%
(-4.90) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2696...
Open
HK$58.60
High
HK$59.00
Low
HK$55.30
Mkt. cap
30.06B
Avg. vol.
828.61K
Volume
1.08M
P/E ratio
31.56
52-wk high
HK$92.00
52-wk low
HK$46.05
EPS
HK$1.75
Shares outstanding
163.43M
No. of employees
4K
Open
HK$58.60
High
HK$59.00
Low
HK$55.30
Mkt. cap
30.06B
Avg. vol.
828.61K
Volume
1.08M
P/E ratio
31.56
52-wk high
HK$92.00
52-wk low
HK$46.05
EPS
HK$1.75
Shares outstanding
163.43M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to 2696 in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for 2696 in the last 3 months.
Highest
Current HK$55.30
HK$119.00 (+115.19%)
Average
HK$99.12 (+79.24%)
Lowest
HK$89.00 (+60.94%)
News stories
From sources across the web
About Shanghai Henlius Biotech Inc
CEOWenjie Zhang
Employees3.76K
Founded2010
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.41B
1.41B
1.92B
1.92B
Cost of goods sold
310.18M
310.18M
530.78M
530.78M
Cost of revenue
310.18M
310.18M
530.78M
530.78M
Research and development expenses
292.73M
292.73M
465.02M
465.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
586.60M
586.60M
734.20M
734.20M
Operating expense
880.84M
880.84M
1.20B
1.20B
Total operating expenses
1.19B
1.19B
1.73B
1.73B
Operating income
218.75M
218.75M
189.81M
189.81M
Other non operating income
540.50K
540.50K
33.20M
33.20M
EBT including unusual items
196.87M
196.87M
208.99M
208.99M
EBT excluding unusual items
196.87M
196.87M
203.58M
203.58M
Income tax expense
1.80M
1.80M
-9.46M
-9.46M
Effective tax rate
0.92%
0.92%
-4.53%
-4.53%
Other operating expenses
-
-
-
-
Net income
195.06M
195.06M
218.46M
218.46M
Net profit margin
13.84%
13.84%
11.36%
11.36%
Earnings per share
-
-
-
-
Interest and investment income
4.74M
4.74M
4.65M
4.65M
Interest expense
-27.17M
-27.17M
-24.08M
-24.08M
Net interest expenses
-22.43M
-22.43M
-19.43M
-19.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
310.75M
310.75M
270.83M
270.83M
Gain or loss from assets sale
129.50K
129.50K
-5.79M
-5.79M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more